• About
  • Subscribe
  • Advertise
  • Contact
Friday, February 13, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Business

Mid-term business plan reviews – are you on track?

by Staff Writer
December 19, 2019
in Business, Practice management
Reading Time: 4 mins read
A A
Share on FacebookShare on Twitter

As 2019 draws to a close, now is the ideal time to analyse your practice’s goals and performance. Karen Crouch explains what needs to be done to guarantee a successful start to 2020.

It’s once again the time of year when we wish all readers a joyful and safe Christmas holiday season to be followed by a happy and prosperous New Year.

It is also an ideal time to dwell on the past six months’ performance against set targets by conducting a mid-term review of your goals for financial year 2019-2020. This is to determine whether any aspect deserves adjustment, upward or downward, in order to meet targets for the end of the financial year.

Large companies go a step further by undertaking QBRs – Quarterly Business Reviews – to track progress on targets and objectives, whether financial, operational (including personnel and personal matters) or client related.

Reviews should address both key elements of the annual business plan:

  • Tactical: ‘business as usual’, day-to-day management framework by which the practice continues to build on identified strengths and avoid negative performances, and
  • Strategic: growth aspirations aimed at optimising new opportunities so that short- and long-term goals are aligned and achievable.

As a valuable starting point, it is necessary to appreciate the fine differences between the practice’s business plan and strategic plan. The business plan is an annual compilation of goals and key performance indicators (KPIs) that includes achievable results, but also ‘stretch’ targets to encourage optimum performance.  It is usually created just prior to each financial year after consultation with key staff and in recognition of the prevailing business environment.

By contrast, the strategic plan is a longer-term projection, say 3 – 5 years, of realistically ‘where you want to be’, not ‘where you would like to be’. Many practices do not have or maintain a strategic plan and instead rely on a best efforts business plan.

For those that do maintain a strategic plan, regular tracking of the business plan against longer-term aspirations is essential to ensure future developments, opportunities and competitive advantages are grasped. For practices that do not maintain a strategic plan, monitoring and reviewing the business plan becomes even more important.

Plan well

Business plan review activities should typically include:

Expenses: budgets on a line-by-line basis (such as wages, insurance). Are they progressing to forecast trends, allowing for cyclical peaks? If the run rates (monthly averages) are higher than set targets, should adjustments to spending practices be considered?

Income: revenues projected for the year, based on practitioner numbers, working hours, charging rates and estimated number of consultations. Are they progressing to set targets? Any shortfall or excess should be carefully analysed as this particular element is vital to achieving a viable practice. Are there new or emerging community or patient demands that should be accommodated? Are there opportunities to differentiate the practice from others by the introduction of a new service?

Non financial: a vital aspect for practices to excel in is patient care. Are service levels (patient satisfaction surveys, wait times) being consistently met? It may be necessary to adjust, or introduce new day-to-day procedures, clinical or administrative, to ensure compliance with changing business imperatives, competition, or external factors like regulatory changes.

Human Resources: this vital element of any business should cover plans to develop staff and practitioners, as well as achieve ‘employer of choice’ status. Is it time to undertake appraisals of staff so they have timely feedback on their performance, encourage good work and address any less-than-satisfactory behaviour?

Marketing/Advertising: are selected advertising channels delivering value for money? How is the success rate of campaigns or individual advertisements being measured? Is it time to review your marketing activity, create greater exposure opportunities or consider a new drive?

Monitoring and Measuring: thoroughness of the overall budgeting system is paramount to tracking progress. Are the employed mechanisms accurate and consistently applied? Are KPIs (such as patient satisfaction and patient numbers) being consistently met, or were they too ambitious and require adjustment?

Obvious conclusions are that a ‘better-than-budget’ performance is a practical way to identify the practice’s strengths and continue doing more of it. While a ‘poorer-than-budget’ outcome is certainly an alert message, it should also present an opportunity to analyse problems and remedy them.

Finally, as part of the measurement and monitoring process, it is advisable to review business plans at least each quarter to ensure end-of-year tactical and strategic goals, including profit targets, will be met. Additionally, practice owners and business planners should remain abreast of developments in the political, regulatory, cultural, social or economic environment which may have potential impacts on practice operations.

From the team at HPC, we wish you a very safe and merry Christmas and a happy 2020.

Karen Crouch is Managing Director of Health Practice Creations Group, a company that assists with practice set ups, administrative, legal, business and financial management. Contact Karen on Email: kcrouch@hpcnsw.com.au or visit www.hpcgroup.com.au

Tags: BusinessBusiness planManagementPractice managementReviewsStrategic plan

Related Posts

Delegating Medicare billing responsibilities does not remove a practice’s accountability. Image: The robynmac/stock.adobe.com.

Protect your practice against Medicare fraud

by Sonya Black and Gail Wang
February 13, 2026

Practice owners and managers need to understand that risk is not just about what goes on in their clinic rooms;...

A Belgian firm has taken a big stake in Rayner. Image: Rayner.

Firm spending $840 million for big stake in Rayner

by Rob Mitchell
February 11, 2026

Belgian investment holding company Groupe Bruxelles Lambert (GBL) is investing €500 million (AU$840  million) in British ophthalmic manufacturer Rayner. An...

Melbourne-based BHG Capital has reportedly agreed a 50% stake in Two Svge. Image: vichie81/stock.adobe.com.

Investor takes big stake in up-and-coming WA eyewear company

by Staff Writer
February 10, 2026

Victorian fund BGH Capital has reportedly taken a nearly 50% stake in Perth-born Two Svge, a direct-to-consumer supplier of bold...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited